Somatostatin-Derived Amyloidosis: A Novel Type of Amyloidosis Associated with Well-Differentiated Neuroendocrine Tumors

被引:0
|
作者
Said, Samar [1 ]
VanTreeck, Benjamin [1 ]
Dasari, Surendra [1 ]
Kurtin, Paul [1 ]
Theis, Jason [1 ]
Nasr, Samih [1 ]
Zhang, Lizhi [1 ]
Yasir, Saba [1 ]
Graham, Rondell [1 ]
McPhail, Ellen [1 ]
机构
[1] Mayo Clin, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
883
引用
收藏
页码:1055 / 1056
页数:2
相关论文
共 50 条
  • [1] Somatostatin-Derived Amyloidosis: A Novel Type of Amyloidosis Associated with Well-Differentiated Neuroendocrine Tumors
    Said, Samar
    VanTreeck, Benjamin
    Dasari, Surendra
    Kurtin, Paul
    Theis, Jason
    Nasr, Samih
    Zhang, Lizhi
    Yasir, Saba
    Graham, Rondell
    McPhail, Ellen
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 1055 - 1056
  • [2] Somatostatin-derived amyloidosis: a novel type of amyloidosis associated with well-differentiated somatostatin-producing neuroendocrine tumours
    Van Treeck, Benjamin J.
    Dasari, Surendra
    Kurtin, Paul J.
    Theis, Jason D.
    Nasr, Samih H.
    Zhang, Lizhi
    Yasir, Saba
    Graham, Rondell P.
    McPhail, Ellen D.
    Said, Samar
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2022, 29 (01): : 58 - 63
  • [3] Somatostatin-derived amyloid deposition associated with duodenal neuroendocrine tumour (NET): a report of novel localised amyloidosis associated with NET
    Ichimata, Shojiro
    Katoh, Nagaaki
    Abe, Ryuta
    Yoshinaga, Tsuneaki
    Kametani, Fuyuki
    Yazaki, Masahide
    Kusama, Yukiko
    Sano, Kenji
    Uehara, Takeshi
    Sekijima, Yoshiki
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2022, 29 (01): : 64 - 65
  • [4] Management of Well-Differentiated Neuroendocrine Tumors
    Tella, Sri Harsha
    Starr, Jason S.
    Kommalapati, Anuhya
    Sonbol, Mohamad Bassam
    Halfdanarson, Thorvardur R.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (09) : 582 - 593
  • [5] Updates on well-differentiated neuroendocrine tumors
    Reidy-Lagunes, Diane
    Wyluda, Ed
    SALUD I CIENCIA, 2012, 18 (08): : 737 - 740
  • [6] Novel therapeutics for patients with well-differentiated gastroenteropancreatic neuroendocrine tumors
    Das, Satya
    Dasari, Arvind
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [7] Initial Treatment of Well-Differentiated Neuroendocrine Tumors
    Dasari, Arvind
    Yao, James
    ONCOLOGY-NEW YORK, 2014, 28 (11): : 945 - 947
  • [8] PDGFRα expression as a novel therapeutic marker in well-differentiated neuroendocrine tumors
    Cavalcanti, Elisabetta
    Ignazzi, Antonia
    De Michele, Francesco
    Caruso, Maria Lucia
    CANCER BIOLOGY & THERAPY, 2019, 20 (04) : 423 - 430
  • [9] Novel Anticancer Agents in Clinical Trials for Well-Differentiated Neuroendocrine Tumors
    Faivre, Sandrine
    Sablin, Marie-Paule
    Dreyer, Chantal
    Raymond, Eric
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2010, 39 (04) : 811 - +
  • [10] Well-differentiated neuroendocrine tumors of the digestive tract: Focus on pancreatic neuroendocrine tumors
    Pellat, Anna
    Barat, Maxime
    Cottereau, Anne-Segolene
    Terris, Benoit
    Coriat, Romain
    BULLETIN DU CANCER, 2023, 110 (09) : 955 - 967